Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
11,879
datasets available to search
ShareScore release 0.9.0
Dataset results
11,879 results for “participation”
A Study of Ramucirumab in Participants With Gastric, Esophageal, and Gastroesophageal Cancer
ClinicalTrials.gov study NCT01246960. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of Lazertinib in Participants With Epidermal Growth Factor Receptor (EGFR) Mutation Positive Advanced Non-Small Cell Lung Cancer (NSCLC)
ClinicalTrials.gov study NCT04075396. IPD Sharing: YES. Countries: 3. Publications: 1.
A Study of Atezolizumab (an Engineered Anti-Programmed Death-Ligand 1 [PD-L1] Antibody) as Monotherapy or in Combination With Bevacizumab (Avastin®) Compared to Sunitinib (Sutent®) in Participants Wit
ClinicalTrials.gov study NCT01984242. IPD Sharing: Not stated. Countries: 9. Publications: 2.
Efficacy and Safety Study of Bimatoprost Sustained-Release (SR) in Participants With Open-angle Glaucoma or Ocular Hypertension
ClinicalTrials.gov study NCT02247804. IPD Sharing: Not stated. Countries: 14. Publications: 2.
A Study to Evaluate Molnupiravir (MK-4482; MOV) in Participants With Severe Renal Impairment (MK-4482-003)
ClinicalTrials.gov study NCT05386758. IPD Sharing: YES. Countries: 1. Publications: 1.
A Multiple Ascending Dose Study of Pegozafermin in Participants With Biopsy Confirmed Nonalcoholic Steatohepatitis (NASH) or Nonalcoholic Fatty Liver Disease (NAFLD) and at High Risk of NASH
ClinicalTrials.gov study NCT04048135. IPD Sharing: UNDECIDED. Countries: 2. Publications: 3.
BTK Inhibitor BGB-3111 in Chinese Participants With Diffuse Large B-Cell Lymphoma (Non-GCB) and Indolent Lymphoma (FL and MZL)
ClinicalTrials.gov study NCT03520920. IPD Sharing: YES. Countries: 1. Publications: 0.
An Asian Study to Evaluate Efficacy and Safety of Oral Enzalutamide in Progressive Metastatic Prostate Cancer Participants
ClinicalTrials.gov study NCT02294461. IPD Sharing: NO. Countries: 4. Publications: 1.
A Study to Assess the Safety of Myozyme® and of Aldurazyme® in Male and Female Participants of Any Age Group With Pompe Disease or With Mucopolysaccharidosis Type I (MPS I) in a Home-care Setting
ClinicalTrials.gov study NCT05073783. IPD Sharing: YES. Countries: 1. Publications: 0.
A Study to Evaluate Rozanolixizumab in Study Participants With Generalized Myasthenia Gravis
ClinicalTrials.gov study NCT04650854. IPD Sharing: YES. Countries: 14. Publications: 2.
A Study of Ataluren in Pediatric Participants With Cystic Fibrosis
ClinicalTrials.gov study NCT00458341. IPD Sharing: Not stated. Countries: 2. Publications: 1.
The Safety and Efficacy of Psilocybin in Participants With Treatment Resistant Depression
ClinicalTrials.gov study NCT03775200. IPD Sharing: Not stated. Countries: 10. Publications: 3.
A Study of Gantenerumab in Participants With Mild Alzheimer Disease
ClinicalTrials.gov study NCT02051608. IPD Sharing: Not stated. Countries: 22. Publications: 1.
A Study for Participants With Spinal Muscular Atrophy (SMA) Who Previously Participated in Nusinersen (ISIS 396443) Investigational Studies
ClinicalTrials.gov study NCT02594124. IPD Sharing: Not stated. Countries: 14. Publications: 0.
A Study of Atezolizumab Compared With a Single-Agent Chemotherapy in Treatment Naïve Participants With Locally Advanced or Recurrent or Metastatic Non-Small Cell Lung Cancer Who Are Deemed Unsuitable
ClinicalTrials.gov study NCT03191786. IPD Sharing: Not stated. Countries: 24. Publications: 4.
Safety and Efficacy of Axicabtagene Ciloleucel in Combination With Rituximab in Participants With Refractory Large B-Cell Lymphoma
ClinicalTrials.gov study NCT04002401. IPD Sharing: YES. Countries: 1. Publications: 2.
A Study of JNJ-73763989, JNJ-56136379, Nucleos(t)Ide Analogs, and Pegylated Interferon Alpha-2a in Virologically Suppressed Participants With Chronic Hepatitis B Virus Infection
ClinicalTrials.gov study NCT04667104. IPD Sharing: YES. Countries: 4. Publications: 1.
A Study Lasmiditan (LY573144) in a Single Migraine Attack in Japanese Participants With Migraine
ClinicalTrials.gov study NCT03962738. IPD Sharing: YES. Countries: 1. Publications: 6.
A Study of Aflibercept Administered in Combination With Pemetrexed and Cisplatin in Participants With Advanced Carcinoma
ClinicalTrials.gov study NCT00794417. IPD Sharing: Not stated. Countries: 2. Publications: 2.
Efficacy and Safety of Roxadustat for Treatment of Anemia in Participants With Lower Risk Myelodysplastic Syndrome With Low Red Blood Cell Transfusion Burden
ClinicalTrials.gov study NCT03263091. IPD Sharing: NO. Countries: 16. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.